High Concordance of Gene Methylation in Post-Digital Rectal Examination and Post-Biopsy Urine Samples for Prostate Cancer Detection
- 30 November 2006
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 176 (5) , 2280-2284
- https://doi.org/10.1016/j.juro.2006.07.047
Abstract
Purpose: We evaluated the concordance between post-digital rectal examination and post-prostate biopsy urine samples using conventional methylation specific polymerase chain reaction analysis of 3 gene promoters in patients with suspected or confirmed prostate cancer. Materials and Methods: Voided urine specimens were collected from 17 men after 15-second digital rectal examination and again after transrectal ultrasound guided biopsy of the prostate for suspected malignancy or for followup biopsy as part of an expectant management protocol. Urine sediment DNA was isolated and subjected to bisulfite modification. Methylation of GSTP1, EDNRB and APC promoters was determined by conventional methylation specific polymerase chain reaction analysis in post-digital rectal examination and post-biopsy samples, and correlated with clinical information. Results: Prostate cancer was detected on prostate biopsy in 12 of 17 patients (71%). Promoter methylation was detected in post-digital rectal examination urine specimens for GSTP1 (24%), APC (12%) and EDNRB (66%). Promoter methylation was detected in post-biopsy urine specimens for GSTP1 (18%), APC (18%) and EDNRB (77%). The concordance between post-digital rectal examination and post-biopsy urine samples was 94% for GSTP1 and APC, and 82% for EDNRB. Overall 100% of patients with biopsy proven prostate cancer had at least 1 gene methylated in urine vs 60% of those without evidence of prostate cancer on biopsy. Conclusions: Gene analysis using conventional methylation specific polymerase chain reaction is a reliable method for detecting abnormal DNA methylation in voided urine samples obtained following digital rectal examination or prostate needle biopsy. The concordance between post-digital rectal examination and post-biopsy urinary samples for promoter methylation is high (82% to 94%), suggesting that urine collected after digital rectal examination may be used for genetic analysis with results similar to those in post-biopsy urine samples.Keywords
This publication has 14 references indexed in Scilit:
- Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control SubjectsJournal of Clinical Oncology, 2005
- Multigene Methylation Analysis for Detection and Staging of Prostate CancerClinical Cancer Research, 2005
- Diagnostic and Prognostic Information in Prostate Cancer with the Help of a Small Set of Hypermethylated Gene LociClinical Cancer Research, 2005
- Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate CancerCancer Research, 2004
- GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancerJournal of Cellular Biochemistry, 2003
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- The fundamental role of epigenetic events in cancerNature Reviews Genetics, 2002
- DNA‐Based Detection of Prostate Cancer in Blood, Urine, and EjaculatesAnnals of the New York Academy of Sciences, 2001
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.Proceedings of the National Academy of Sciences, 1994